Clinical Characterization and Molecular Profiling by Targeted Next‐Generation Sequencing in a Large Indian Cohort With 46,XY Differences in Sex Development
Clinical Endocrinology · 2026-06 · 104 (6) · 612-627
DOI: 10.1111/cen.70122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Endocrinology, online erschienen am 08.03.2026. Verfasst von Vandana Jain und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Endocrinology, All India Institute of Medical Sciences, New Delhi, India. Hauptthemen laut MEDLINE: High-Throughput Nucleotide Sequencing, Disorder of Sex Development, 46,XY, Sexual Development. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Indian Council of Medical Research, Bundesministerium fÜr Bildung und Forschung, the Indian Council of Medical Research, New Delhi.
Abstract (Originalsprache)
Background
46,XY differences in sex development (DSD) comprise a heterogeneous group of conditions. Molecular diagnosis guides management by giving insights into the pathophysiology of sex development, reproduction, tumour formation and extragenital issues.
Methods
Children with 46,XY DSD from a tertiary hospital in India underwent comprehensive assessment and stepwise genetic testing. Targeted testing for SRD5A2 and AR was performed in cases with suspected 5α‐reductase type 2 (5αR2) deficiency/androgen insensitivity syndrome (AIS). For all other patients, and those without variants in SRD5A2 or AR on Sanger sequencing, NGS using a targeted 155‐gene panel was performed. Longitudinal clinical data was also collated.
Results
One hundred and forty‐seven children with 46,XY DSD with a median (interquartile range) age of 3.8 (1.4, 10.6) years were enrolled. Provisional clinical diagnoses were 5αR2 deficiency/AIS ( n = 83, 56.5%), gonadal dysgenesis ( n = 31, 21%), testosterone biosynthetic defect ( n = 11, 7.5%) and others ( n = 22, 15%) based on clinical, biochemical and radiological assessment. Sequential single gene testing for SRD5A2 and AR performed in 75 patients with a clinical diagnosis of 5αR2 deficiency/AIS identified pathogenic/likely pathogenic variants in 44 subjects. NGS in the remaining 103 children revealed pathogenic/likely pathogenic variants in 20 subjects across 12 genes, with NR5A1 being the most frequent (7/103). Four subjects had variants of uncertain significance (VUS) deemed possibly pathogenic due to good genotype‐phenotype correlation. Overall, 68/147 (46%) achieved a molecular diagnosis in this cohort.
Conclusion
Sanger sequencing followed by NGS could provide molecular diagnosis in 46% of this Indian cohort with 46,XY DSD . SRD5A2 , AR and NR5A1 were the most frequently implicated genes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pediatric Endocrinology, All India Institute of Medical Sciences, New Delhi, India.
- Department of Pediatric Surgery, All India Institute of Medical Sciences, New Delhi, India.
- Division of Pediatric and Adolescent Endocrinology, Indira Gandhi Institute of Child Health, Bangalore, India.
- Division of Pediatric Endocrinology and Diabetes, Department of Pediatric and Adolescent Medicine, University of Lübeck, Lübeck, Germany.
- Council of Scientific and Industrial Research - Institute of Genomics and Integrative Biology (CSIR-IGIB), New Delhi, India.
ORCID-Profile: Vandana Jain, Sukanya Priyadarshini, Rajni Sharma, Shilpa Sharma, Palany Raghupathy, Ralf Werner, Olaf Hiort, Mohammed Faruq
Förderung
- Indian Council of Medical Research
- Bundesministerium fÜr Bildung und Forschung
- the Indian Council of Medical Research, New Delhi
- German Ministry for Research and Education
Zitieren
APA
Jain, V., Priyadarshini, S., Sharma, R., Kumar, A., Sharma, S., Raghupathy, P., Ralf Werner, Hiort, O., & Faruq, M. (2026). Clinical Characterization and Molecular Profiling by Targeted Next‐Generation Sequencing in a Large Indian Cohort With 46,XY Differences in Sex Development. Clinical Endocrinology, 104(6), 612-627. https://doi.org/10.1111/cen.70122
Vancouver
Jain V, Priyadarshini S, Sharma R, Kumar A, Sharma S, Raghupathy P, et al. Clinical Characterization and Molecular Profiling by Targeted Next‐Generation Sequencing in a Large Indian Cohort With 46,XY Differences in Sex Development. Clinical Endocrinology. 2026;104(6):612-627. doi:10.1111/cen.70122
BibTeX
@article{Jain2026,
author = {Jain, Vandana and Priyadarshini, Sukanya and Sharma, Rajni and Kumar, Anil and Sharma, Shilpa and Raghupathy, Palany and Ralf Werner and Hiort, Olaf and Faruq, Mohammed},
title = {Clinical Characterization and Molecular Profiling by Targeted Next‐Generation Sequencing in a Large Indian Cohort With 46,XY Differences in Sex Development},
journal = {Clinical Endocrinology},
year = {2026},
volume = {104},
number = {6},
pages = {612--627},
doi = {10.1111/cen.70122}
}
EUVIMED